U
UnionClin
Shanghai clinical CRO focused on oncology and specialty indications
About UnionClin
Shanghai UnionClin Pharmaceutical Technology Co., Ltd. (联斯达 / UnionClin) is a clinical contract research organization founded in 2017 and headquartered in Shanghai. It provides end-to-end clinical trial services spanning strategy consulting, regulatory and medical affairs, clinical operations, data management and statistics, clinical pharmacology, pharmacovigilance, IRC, bioanalysis, site management and FSP support, with therapeutic focus on oncology, autoimmune disease, infectious disease, neurology and cardiovascular disease. Company materials cite roughly 500 employees across 100+ Chinese cities, collaboration with 2,000+ clinical experts and 1,000+ research centres, and experience supporting hundreds of innovative-drug trials including China–US dual filings.
Source: Dealroom company dataAt a glance
- Founded
- 2017
- Headquarters
- Huangpu, China
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Cenova Capital
CICC
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about UnionClin on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See UnionClin on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.